Accelerated amyloid deposition in mice treated with the aspartic protease inhibitor, pepstatin

Journal of Immunology

Volumn 157, Issue 2, 1996, Pages 901-907

  Yamada, Toshiyuki ^a   Liepnieks, Juris ^a,b   Benson, Merrill D ^a,b   Kluve Beckerman, Barbara ^a,c  

^a INDIANA UNIVERSITY   (United States)

^b Richard L Roudeboush Vet Aff M   (United States)

^c RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID A PROTEIN; ASPARTIC PROTEINASE; ASPARTIC PROTEINASE INHIBITOR; CASEIN; PEPSTATIN;

AMYLOIDOSIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SERUM; SPLEEN;

ANIMALS; APOLIPOPROTEINS; ASPARTIC ENDOPEPTIDASES; ENZYME ACTIVATION; FEMALE; IMMUNOHISTOCHEMISTRY; LIVER; MICE; MICE, INBRED CBA; PEPSTATINS; PROTEIN PRECURSORS; RNA, MESSENGER; SERUM AMYLOID A PROTEIN; UP-REGULATION;

EID: 0029960572     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Glenner, G. G. 1980. Amyloid deposits and amyloidosis. The β-fibrilloses. N. Engl. J. Med. 302:1283.
2. Husby, G., G. Marhaug, B. Dowton, K. Sletten, and J. D. Sipe. 1994. Serum amyloid A (SAA): biochemistry, genetics, and pathogenesis of AA amyloidosis. Amyloid: Int. J. Exp. Clin. Invest. 1:119.
3. Sipe, J. D., H. Rokita, and F. C. de Beer. 1993. Cytokine regulation of the mouse SAA gene family. In Acute Phase Proteins: Molecular Biology, Biochemistry, and Clinical Applications. A. Mackiewicz, I. Kushner, and H. Baumann, eds. CRC Press, Boca Raton, FL, p. 511.
4. Pepys, M. B. 1988. Amyloidosis. In Immunological Diseases, 4th Ed. M. Samter, K. F. Austen, H. N. Claman, M. M. Frank, and D. W. Talmadge, eds. Little, Brown and Co., Boston, MA, p. 631.
5. Lyon, A. W., S. Narindrasorasak, I. D. Young, T. Anastassiades, J. R. Couchman, K. J. McCarthy, and R. Kisilevsky. 1991. Co-deposition of basement membrane components during the induction of murine splenic AA amyloid. Lab. Invest. 64:785.
6. Kawahara, E., M. Shiroo, I. Nakanishi, and S. Migita. 1989. The role of fibronectin in the development of experimental amyloidosis: evidence of immunohistochemical codistribution and binding property with serum amyloid A. Am. J. Pathol. 134:1305.
7. Wisniewski, T., and B. Frangione. 1992. Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci. Lett. 135:235.
8. Hoffman, J. S., and E. P. Benditt. 1983. Plasma clearance kinetics of the amyloid-related high density lipoprotein apoprotein, serum amyloid protein (apoSAA), in the mouse. J. Clin. Invest. 71:926.
9. Tape, C., and R. Kisilevsky. 1990. Apolipoprotein A-I and apolipoprotein SAA half-lives during acute inflammation and amyloidogenesis. Biochim. Biophys. Acta. 1043:295.
10. Gollaher, C. J., and L. L. Bausserman. 1990. Hepatic catabolism of serum amyloid A during an acute phase response and chronic inflammation. Proc. Soc. Exp. Biol. Med. 194:245.
11. Miura, K., Y. Takahashi, and H. Shirasawa. 1985. Immunohistochemical detection of serum amyloid A protein in the liver and the kidney after casein injection. Lab. Invest. 53:453.
12. Meek, R. L., N. Eriksen, and E. P. Benditt. 1989. Serum amyloid A in the mouse: sites of uptake and mRNA expression. Am. J. Pathol. 135:411.
13. Lavie, G., D. Zucker-Franklin, and E. C. Franklin. 1980. Elastase-type proteases on the surface of human blood monocytes: possible role in amyloid formation. J. Immunol. 125:175.
14. Silverman, S. L., E. S. Cathcart, M. Skinner, and A. S. Cohen. 1982. The degradation of serum amyloid A protein by activated polymorphonuclear leucocytes: participation of granulocyte elastase. Immunology 46:737.
15. Shephard, E. G., F. C. de Beer, M. C. de Beer, M. S. Jeenah, G. A. Coetzee, and D. R. van der Westhuyzen. 1987. Neutrophil association and degradation of normal and acute-phase high-density lipoprotein 3. Biochem. J. 248:919.
16. Shirahama, T., and A. S. Cohen. 1975. Intralysosomal formation of amyloid fibrils. Am. J. Pathol. 81:101.
17. Takahashi, M., T. Yokota, H. Kawano, T. Gondo, T. Ishihara, and F. Uchino. 1989. Ultrastructual evidence for intracellular formation of amyloid fibrils in macrophages. Virchows. Arch. A. Pathol. Anal. Histopathol. 415:411.
18. Chronopoulos, S., D. W. Laird, and Z. Ali-Khan. 1994. Immunolocalization of serum amyloid A and AA amyloid in lysosomes in murine monocytoid cells: confocal and immunogold electron microscopic studies. J. Pathol. 173:361.
19. Miura, K., and H. Shirasawa. 1994. Amyloid A (AA) fibril formation in renal tubules occurs intracytoplasmically, possibly at the site of membrane assembling structures. Amyloid: Int. J. Exp. Clin. Invest. 1:107.
20. Baba, S., K. Miura, and H. Shirasawa. 1991. In vitro assembly of murine amyloid A protein, two murine serum amyloid A proteins, and normal human transthyretin to form amyloid-like fibrils. In Amyloid and Amyloidosis. J. B. Natvig, O. Forre, G. Husby, A. Husebekk, B. Skogen, K. Sletten, and P. Westermark, eds. Kluwer Academic Publishers, Dordrecht, The Netherlands, p. 497.
21. Westermark, G. T., U. Engstrom, and P. Westermark. 1992. The N-terminal segment of protein AA determines its fibrillogenic potential. Biochem. Biophys. Res. Commun. 182:27.
22. Yamada, T., B. Kluve-Beckerman, J. J. Liepnieks, and M. D. Benson. 1994. Fibril formation from recombinant serum amyloid A. Biochim. Biophys. Acta 1226:323.
23. Stone, P. J., J. M. Campistol, C. R. Abraham, O. Rodgers, T. Shirahama, and M. Skinner. 1993. Neutrophil proteases associated with amyloid fibrils. Biochem. Biophys. Res. Commun. 197:130.
24. Yamada, T., J. J. Liepnieks, B. Kluve-Beckerman, and M. D. Benson. 1995. Cathepsin B generates the most common form of amyloid A (AA76) from degradation of serum amyloid A. Scand. J. Immunol. 41:94.
25. Yamada, T., B. Kluve-Beckerman, J. J. Liepnieks, and M. D. Benson. 1995. In vitro degradation of serum amyloid A by cathepsin D and other acid proteases: possible protection against amyloid fibril formation. Scand. J. Immunol. 41:570.
26. Ohnishi, H., K. M. Lin, and T. M. Chu. 1990. Prolongation of serum half-life of interleukin 2 and augmentation of lymphokine-activated killer cell activity by pepstatin in mice. Cancer Res. 50:1107.
27. Barren, A. J. 1967. Lysosomal acid proteinase of rabbit liver. Biochem. J. 104: 601.
28. Kluve-Beckerman, B., M. Song, M. D. Benson, and J. J. Liepnieks. 1993. Recombinant murine serum amyloid A from baculovirus-infected insect cells: purification and characterization. Biochim. Biophys. Acta 1182:303.
29. Schagger, H., and G. von Jagow. 1987. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 166:368.
30. Sipe, J. D., W. A. Gonnerman, L. D. Loose, G. Knapschaefer, W. J. Xie, and C. Franzblau. 1989. Direct binding enzyme-linked immunosorbent assay (ELISA) for serum amyloid A (SAA). J. Immunol. Methods 125:125.
31. Yamada, T., W. M. Kuster, B. Kluve-Beckerman, J. J. Liepnieks, and M. D. Benson. 1994. Measurement of serum amyloid A4 (SAA4): Its constitutive presence in serum. Amyloid: Int. J. Exp. Clin. Invest. 1:114.
32. Godenir, N. L., M. S. Jeenah, G. A. Coetzee, D. R. van der Westhuyzen, A. G. Strachan, and F. C. de Beer. 1985. Standardization of the quantitation of serum amyloid A protein (SAA) in human serum. J. Immunol. Methods 83:217.
33. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156.
34. Yamamoto, K-I., and S. Migita. 1985. Complete primary structures of two major mutine serum amyloid A proteins deduced from cDNA sequences. Proc. Natl. Acad. Sci. USA 82:2915.
35. Goldsmith, M. R., E. C. Rattner, M. M. D. Koehler, S. R. Balikov, and S. C. Bock. 1979. Two-dimensional electrophoresis of small-molecular-weight proteins. Anal. Biochem. 99:33.
36. Badolato, R., J. M. Wang, W. J. Murphy, A. R. Lloyd, D. F. Michiel, L. L. Bausserman, D. J. Kelvin, and J. J. Oppenheim. 1994. Serum amyloid A is a chemo-attractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes. J. Exp. Med. 180:203.
37. Shirahama, T., K. Miura, S. T. Ju, R. Kisilevsky, E. Gruys, and A. S. Cohen. 1990. Amyloid enhancing factor-loaded macrophages in amyloid fibril formation. Lab. Invest. 62:61.
38. Ohnishi, H., J. T. Y. Chao, K. M. Lin, H. Lee, and T. M. Chu. 1989. The role of the kidney in metabolic change of Il-2. Tumor Biol. 10:202.
39. Suzuki, T., S. Ishikawa, T. Motoyama, and S. Oboshi. 1980. Suppression and acceleration of experimental amyloidosis in the mouse model. Acta. Pathol. Jpn. 30:557.
40. Tomino, I., H. Okamori, T. Hashimoto, and E. Tsubura. 1987. The effect of EST (thiol protease inhibitor) to the experimental murine amyloidosis. In Annual Report of the Ministry of Health and Welfare Primary Amyloidosis Research Committee Tokyo, Japan, (English Abstr.), p. 31.